GLYCODX
DEAD

Serial Number

86790734

Owner

OBI PHARMA, INC.

Attorney

Ran He

Filing Date

Oct 16, 2015

Add to watchlist:

No watchlists yet
View on USPTO

GLYCODX Trademark

Serial Number: 86790734 • Registration: 5583190

GLYCODX is a trademark filed by OBI PHARMA, INC. on October 16, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

OBI PHARMA, INC. (12 trademarks)

Nankang Software Park
Taipei 11503 , TW

Entity Type: 03

Trademark Details

Filing Date

October 16, 2015

Registration Date

October 16, 2018

Published for Opposition

July 31, 2018

Cancellation Date

May 2, 2025

Goods & Services

amino acids for medical purposes; biological preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; blood for medical purposes; blood plasma; capsules sold empty for pharmaceuticals; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; detergents for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; drugs for medical purpose, namely, pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for treatment of immune system related diseases, cancer and infectious diseases; reagent paper for medical purposes; medicated serums for treatment of immune system related diseases, cancer and infectious diseases; sugar for medical purposes; vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and antiangiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers

Filing History

CANCELLED SEC. 8 (6-YR)
May 2, 2025 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2024 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 27, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 27, 2024 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 16, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 31, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 31, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 11, 2018 NONP
1(B) BASIS DELETED; NEW BASIS REQUESTED
Jun 22, 2018 ADBS
NOTICE OF ALLOWANCE CANCELLED
Jun 22, 2018 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Jun 21, 2018 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Jun 21, 2018 PCBG
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Jun 21, 2018 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Jun 21, 2018 PCBG
TEAS RESPONSE TO PETITION INQUIRY LETTER
Jun 12, 2018 ERTI
PETITION INQUIRY LETTER ISSUED
Jun 4, 2018 PILM
ASSIGNED TO PETITION STAFF
Jun 1, 2018 APET
PAPER RECEIVED
May 1, 2018 MAIL
TEAS PETITION TO AMEND BASIS RECEIVED
Apr 27, 2018 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2018 EXRA
SOU EXTENSION 3 GRANTED
Mar 26, 2018 EX3G
SOU EXTENSION 3 FILED
Mar 26, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 26, 2018 EEXT
ASSIGNED TO EXAMINER
Feb 20, 2018 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 6, 2017 EXRA
SOU EXTENSION 2 GRANTED
Oct 4, 2017 EX2G
SOU EXTENSION 2 FILED
Oct 4, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 4, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2017 EXRA
SOU EXTENSION 1 GRANTED
Mar 8, 2017 EX1G
SOU EXTENSION 1 FILED
Mar 8, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 8, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 25, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 30, 2016 NPUB
PUBLISHED FOR OPPOSITION
Aug 30, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 10, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 26, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2016 CRFA
ASSIGNED TO LIE
Jul 14, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 8, 2016 GNRN
NON-FINAL ACTION E-MAILED
Feb 8, 2016 GNRT
NON-FINAL ACTION WRITTEN
Feb 8, 2016 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2015 NWOS
NEW APPLICATION ENTERED
Oct 20, 2015 NWAP